The State of Ohio Board of Pharmacy (SOBP) recently published three new guidance documents regarding recent law and rule changes that may pertain to family physicians and family medicine practices. They include the following:
- Effective Saturday, April 1, 2017, all prescribers that possess compounded drugs or engage in the compounding of dangerous drugs (i.e. prescription drugs) must obtain a Terminal Distributor of Dangerous Drugs (TDDD) license (Ohio Revised Code 4729.541). More information on this provision can be found on the SOBP website.
- TDDD License Requirements for Controlled Substances: All locations that possess controlled substances are required to obtain licensure as a category III TDDD. Please be advised that this requirement takes effect on Thursday, April 6, 2017. More information on this provision can be found on the SOBP website.
- Office-Based Opioid Treatment: Effective Friday, August 4, 2017, all locations that treat more than 30 individuals for opioid dependence or addiction using a controlled substance are required to obtain a TDDD license with an office-based opioid treatment classification. Please be advised that there are some exemptions to this requirement. More information on this provision can be found on the SOBP website.